SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Thompson Siegel & Walmsley LLC

Thompson Siegel & Walmsley LLC decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 14.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,200 shares of the exchange traded fund’s stock after selling 1,350 shares during the quarter. Thompson Siegel & Walmsley LLC’s holdings in SPDR S&P Biotech ETF were worth $738,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Golden State Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $29,000. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $29,000. Avior Wealth Management LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 393.6% in the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after buying an additional 307 shares during the period. Tidemark LLC raised its position in shares of SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares during the period. Finally, Bank of Jackson Hole Trust acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth $43,000.

SPDR S&P Biotech ETF Stock Up 1.3 %

Shares of SPDR S&P Biotech ETF stock opened at $87.13 on Friday. The stock’s fifty day moving average is $90.06 and its 200-day moving average is $94.86. The firm has a market capitalization of $5.75 billion, a PE ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.